BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3181110)

  • 1. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
    Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
    Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical effects of a calcium supplement in osteoporotic postmenopausal women with normal absorption and malabsorption of calcium.
    Need AG; Horowitz M; Philcox JC; Nordin BE
    Miner Electrolyte Metab; 1987; 13(2):112-6. PubMed ID: 3696089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Am J Clin Nutr; 1984 Jun; 39(6):857-9. PubMed ID: 6720619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.
    Need AG; Horowitz M; Philcox JC; Nordin BE
    Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical effects of a calcium supplement in postmenopausal women with primary hyperparathyroidism.
    Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
    Horm Metab Res; 1994 Jan; 26(1):39-42. PubMed ID: 8150422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover in spinal osteoporosis.
    Pødenphant J; Johansen JS; Thomsen K; Riis BJ; Leth A; Christiansen C
    J Bone Miner Res; 1987 Dec; 2(6):497-503. PubMed ID: 3502682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90.
    Prince RL; Dick I; Devine A; Price RI; Gutteridge DH; Kerr D; Criddle A; Garcia-Webb P; St John A
    J Bone Miner Res; 1995 Jun; 10(6):835-42. PubMed ID: 7572305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of salt restriction on urine hydroxyproline excretion in postmenopausal women.
    Need AG; Morris HA; Cleghorn DB; De Nichilo D; Horowitz M; Nordin BE
    Arch Intern Med; 1991 Apr; 151(4):757-9. PubMed ID: 2012460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss?
    Riis BJ; Nilas L; Christiansen C
    Bone Miner; 1987 Feb; 2(1):1-9. PubMed ID: 3504720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women.
    Scopacasa F; Need AG; Horowitz M; Wishart JM; Morris HA; Nordin BE
    Horm Metab Res; 2002 Jan; 34(1):44-7. PubMed ID: 11833002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
    Campusano C; López JM; Campino C; Cárdenas I; Rojas A
    Rev Med Chil; 2000 Apr; 128(4):387-91. PubMed ID: 10962855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women.
    Marshall RW; Selby PL; Chilvers DC; Hodgkinson A
    Horm Metab Res; 1984 Feb; 16(2):97-9. PubMed ID: 6706290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and osteoporosis.
    Nordin BE; Polley KJ; Need AG; Morris HA; Horowitz H
    Ann Chir Gynaecol; 1988; 77(5-6):212-8. PubMed ID: 3076047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical markers of bone remodeling and bone density in healthy postmenopausal women].
    Campusano C; López JM; González G; Rojas A; Arteaga E; Rodríguez J
    Rev Med Chil; 1993 Sep; 121(9):1000-5. PubMed ID: 8191148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of three different calcium preparations on urinary calcium and hydroxyproline excretion in postmenopausal osteoporotic women.
    Need AG; Horowitz M; Morris HA; Nordin BE
    Eur J Clin Nutr; 1991 Jul; 45(7):357-61. PubMed ID: 1935862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting urinary sodium/creatinine in relation to calcium/creatinine and hydroxyproline/creatinine in a general population of women.
    Goulding A
    N Z Med J; 1981 May; 93(683):294-7. PubMed ID: 6942284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.